SI1408038T1 - Imidazole deriviatives and their use as peripherally-selective inhibitors of dopamine-beta-hydroxylase - Google Patents
Imidazole deriviatives and their use as peripherally-selective inhibitors of dopamine-beta-hydroxylaseInfo
- Publication number
- SI1408038T1 SI1408038T1 SI200331309T SI200331309T SI1408038T1 SI 1408038 T1 SI1408038 T1 SI 1408038T1 SI 200331309 T SI200331309 T SI 200331309T SI 200331309 T SI200331309 T SI 200331309T SI 1408038 T1 SI1408038 T1 SI 1408038T1
- Authority
- SI
- Slovenia
- Prior art keywords
- deriviatives
- hydroxylase
- dopamine
- peripherally
- imidazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0223719A GB2393958A (en) | 2002-10-11 | 2002-10-11 | Peripherally-selective imidazole inhibitors of dopamine-beta-hydroxylase |
| GB0224306A GB2394223B (en) | 2002-10-11 | 2002-10-18 | Peripherally-selective inhibitors of dopamine-beta-hydroxylase and method of their preparation |
| EP03256420A EP1408038B1 (en) | 2002-10-11 | 2003-10-10 | Imidazole deriviatives and their use as peripherally-selective inhibitors of dopamine-beta-hydroxylase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1408038T1 true SI1408038T1 (en) | 2008-10-31 |
Family
ID=9945777
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200331309T SI1408038T1 (en) | 2002-10-11 | 2003-10-10 | Imidazole deriviatives and their use as peripherally-selective inhibitors of dopamine-beta-hydroxylase |
| SI200331986T SI1908760T1 (en) | 2002-10-11 | 2003-10-10 | Chromane and thiochromane-3-yl-1,3-dihydroimidazoles as inhibitors of dopamine-beta-hydroxylase and methods of their preparation |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200331986T SI1908760T1 (en) | 2002-10-11 | 2003-10-10 | Chromane and thiochromane-3-yl-1,3-dihydroimidazoles as inhibitors of dopamine-beta-hydroxylase and methods of their preparation |
Country Status (11)
| Country | Link |
|---|---|
| KR (1) | KR101350741B1 (en) |
| CN (1) | CN100393715C (en) |
| AR (2) | AR041589A1 (en) |
| AT (5) | ATE505465T1 (en) |
| CY (2) | CY1108452T1 (en) |
| DE (4) | DE60336276D1 (en) |
| DK (2) | DK1908760T3 (en) |
| ES (5) | ES2384118T3 (en) |
| GB (2) | GB2393958A (en) |
| HK (1) | HK1116188A1 (en) |
| SI (2) | SI1408038T1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0708818D0 (en) * | 2007-05-08 | 2007-06-13 | Portela & Ca Sa | Compounds |
| EP2655363B1 (en) * | 2010-12-22 | 2017-04-12 | Bial-Portela & CA, S.A. | Crystalline forms and processes for their preparation |
| GB201316410D0 (en) | 2013-09-13 | 2013-10-30 | Bial Portela & Ca Sa | Processes for preparing peripherally-selective inhibitors of dopamine-?-hydroxylase and intermediates for use therein |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL82401A0 (en) * | 1986-05-06 | 1987-11-30 | Merrell Dow Pharma | Dopamine beta hydroxy-lase inhibiting imidazole derivatives and pharmaceutical compositions containing them |
| US4868210A (en) | 1988-03-30 | 1989-09-19 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| CZ290082B6 (en) * | 1994-04-26 | 2002-05-15 | Syntex (U. S. A.) Inc. | Benzocycloalkylazolethione derivatives, pharmaceutical preparation containing thereof, process of their preparation and intermediates of the preparation process |
-
2002
- 2002-10-11 GB GB0223719A patent/GB2393958A/en not_active Withdrawn
- 2002-10-18 GB GB0224306A patent/GB2394223B/en not_active Expired - Lifetime
-
2003
- 2003-10-10 DE DE60336276T patent/DE60336276D1/en not_active Expired - Lifetime
- 2003-10-10 KR KR1020127005102A patent/KR101350741B1/en active IP Right Grant
- 2003-10-10 AT AT07076125T patent/ATE505465T1/en active
- 2003-10-10 ES ES07076123T patent/ES2384118T3/en not_active Expired - Lifetime
- 2003-10-10 ES ES07076124T patent/ES2361939T3/en not_active Expired - Lifetime
- 2003-10-10 ES ES03256420T patent/ES2309279T3/en not_active Expired - Lifetime
- 2003-10-10 SI SI200331309T patent/SI1408038T1/en unknown
- 2003-10-10 DE DE60336275T patent/DE60336275D1/en not_active Expired - Lifetime
- 2003-10-10 AT AT07076122T patent/ATE500248T1/en not_active IP Right Cessation
- 2003-10-10 AT AT03256420T patent/ATE403652T1/en active
- 2003-10-10 DK DK07076125.9T patent/DK1908760T3/en active
- 2003-10-10 ES ES07076125T patent/ES2364919T3/en not_active Expired - Lifetime
- 2003-10-10 AT AT07076124T patent/ATE500247T1/en not_active IP Right Cessation
- 2003-10-10 DK DK03256420T patent/DK1408038T3/en active
- 2003-10-10 ES ES07076122T patent/ES2361938T3/en not_active Expired - Lifetime
- 2003-10-10 DE DE60336772T patent/DE60336772D1/en not_active Expired - Lifetime
- 2003-10-10 CN CNB2003801059426A patent/CN100393715C/en not_active Expired - Fee Related
- 2003-10-10 AR ARP030103711A patent/AR041589A1/en active IP Right Grant
- 2003-10-10 SI SI200331986T patent/SI1908760T1/en unknown
- 2003-10-10 AT AT07076123T patent/ATE550335T1/en active
- 2003-10-10 DE DE60322642T patent/DE60322642D1/en not_active Expired - Lifetime
-
2008
- 2008-10-09 HK HK08111214.9A patent/HK1116188A1/en not_active IP Right Cessation
- 2008-10-24 CY CY20081101204T patent/CY1108452T1/en unknown
-
2011
- 2011-07-01 CY CY20111100639T patent/CY1112457T1/en unknown
-
2014
- 2014-03-18 AR ARP140101283A patent/AR095674A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB2394223B (en) | 2007-05-16 |
| CY1108452T1 (en) | 2014-04-09 |
| AR095674A2 (en) | 2015-11-04 |
| DK1908760T3 (en) | 2011-07-25 |
| ES2384118T3 (en) | 2012-06-29 |
| DE60336276D1 (en) | 2011-04-14 |
| DE60336772D1 (en) | 2011-05-26 |
| DE60336275D1 (en) | 2011-04-14 |
| GB0224306D0 (en) | 2002-11-27 |
| CY1112457T1 (en) | 2015-12-09 |
| SI1908760T1 (en) | 2011-05-31 |
| AR041589A1 (en) | 2005-05-26 |
| CN100393715C (en) | 2008-06-11 |
| ATE500248T1 (en) | 2011-03-15 |
| KR20120038014A (en) | 2012-04-20 |
| ATE550335T1 (en) | 2012-04-15 |
| DK1408038T3 (en) | 2008-11-24 |
| ATE505465T1 (en) | 2011-04-15 |
| GB2394223A (en) | 2004-04-21 |
| HK1116188A1 (en) | 2008-12-19 |
| ATE403652T1 (en) | 2008-08-15 |
| ES2361939T3 (en) | 2011-06-24 |
| ATE500247T1 (en) | 2011-03-15 |
| GB2393958A (en) | 2004-04-14 |
| GB0223719D0 (en) | 2002-11-20 |
| KR101350741B1 (en) | 2014-01-10 |
| CN1726211A (en) | 2006-01-25 |
| ES2309279T3 (en) | 2008-12-16 |
| DE60322642D1 (en) | 2008-09-18 |
| ES2364919T3 (en) | 2011-09-16 |
| ES2361938T3 (en) | 2011-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL166780A0 (en) | Use of ikappab-kinase inhibitors in pain therapy | |
| HRP20041029A2 (en) | Therapeutic use of selcetive pde10 inhibitors | |
| AU2003303128A8 (en) | Inhibitors and methods of use thereof | |
| PL372814A1 (en) | Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors | |
| PL2305250T3 (en) | Benzimidazole derivatives and their use as protein kinases inhibitors | |
| AU2003217870A8 (en) | Pini-modulating compounds and methods of use thereof | |
| IL172627A0 (en) | Hydrolytically-resistant boron-containing therapeutics and methods of use | |
| AU2003259735A8 (en) | Small-mer compositions and methods of use | |
| IL173174A0 (en) | Inhibitors of akt activity | |
| EP1620095A4 (en) | Inhibitors of akt activity | |
| EP1465615A4 (en) | Tricyclic-bis-enone derivatives and methods of use thereof | |
| AU2003213673A8 (en) | Pin1-modulating compounds and methods of use thereof | |
| GB0324761D0 (en) | Use of compounds in therapy | |
| ZA200410409B (en) | Use of thio-oxindole derivatives in treatment of hormonerelated conditions | |
| EP1586332A4 (en) | Combined use of carnosinase inhibitor with l-carnosines and composition | |
| EP1613266A4 (en) | Methods of treating pain and compositions for use therefor | |
| EP1691812A4 (en) | Gtpase inhibitors and methods of use | |
| AU2003299441A8 (en) | Nf-hev compositions and methods of use | |
| EP1476150A4 (en) | Carboxyfullerenes and methods of use thereof | |
| PL374581A1 (en) | Diaminothiazoles and use thereof as cdk4 inhibitors | |
| EP1633749A4 (en) | Deazaflavin compounds and methods of use thereof | |
| GB0207411D0 (en) | Azole compounds and their therapeutic use | |
| EP1802737A4 (en) | Tissue system and methods of use | |
| PL380189A3 (en) | Azolidinecarbonitriles and their use as dpp-iv inhibitors | |
| EP1545287A4 (en) | Vasoregulating compounds and methods of their use |